Skip to content
  1. Home
  2. Medications & hormones
  3. Ibuprofen

Ibuprofen

NSAID. Regular use around training suppresses the inflammatory signal that drives adaptation, so a week of it is worth seeing next to your training log.

Medications & hormones

Recovery & healing

Research records

Historical source snapshot. Not freshly verified, not a recommendation. Study findings, community accounts and app defaults are not interchangeable.

Publication suitability · 2026-10-15: Historical reference only; not a clinical verification. Clinical, regulatory, efficacy, safety and dose claims are not independently established by this review.

Ibuprofen

NSAID. Regular use around training suppresses the inflammatory signal that drives adaptation, so a week of it is worth seeing next to your training log.

Evidence category: Regulator / guideline. This describes the source category, not approval or certainty.

Regulatory statement in source: FDA-approved.

Ibuprofen is a non-steroidal anti-inflammatory drug. A standard clinical reference lists its FDA-approved uses, including mild to moderate pain, fever, period pain, osteoarthritis and rheumatoid disorders. It blocks cyclooxygenase enzymes, which lowers prostaglandin production and so reduces pain and inflammation. Known risks include stomach bleeding, kidney impairment and cardiovascular events. The sources are a reference text and a narrative review, not new trial data.

Benefits reported in the imported source

  • Mild to moderate pain, fever, period pain and arthritic conditions.
  • The mechanism is established: blocking cyclooxygenase lowers prostaglandins, pain and inflammation

Risks and limits

  • Known risks include stomach bleeding, kidney impairment and cardiovascular events
  • The sources are a reference text and a narrative review, not new trial data

Source bottom line: Ibuprofen is an approved anti-inflammatory painkiller with well-known stomach, kidney and cardiovascular risks.

Uncertainty: Reference information only. Not medical advice.

Study protocols — reports, not instructions

adults and children 12 years and over, per the US over-the-counter Motrin IB label

Reported regimen
one 200 mg tablet every 4 to 6 hours while symptoms last, two tablets if one does not help, not more than 6 tablets in 24 hours
Duration
up to 10 days for pain and 3 days for fever without seeing a doctor
Reported outcome
The label's approved uses are temporary relief of minor aches and pains and temporary reduction of fever.
Source
Motrin IB (ibuprofen) — US label (DailyMed)
Claim provenance

evidence.json#/catalog:medication:ibuprofen/protocols/0

Community and practice descriptions

Accounts of a practice are not evidence of safety or effectiveness. Words such as “standard”, “safe” or “recommended” describe the source account, not verified consensus or this wiki’s advice. Commercial and self-published citations are retained for traceability, not vendor endorsement or independent clinical corroboration.

Historical research outcome: no-verified-description · 2026-10-06

No suitable community description was independently verified in these checks. The entry remains empty; this does not establish that no practice exists elsewhere. The proposed text only lists available dosage forms; no community routine is documented.

Pharmacokinetic context

Historical half-life estimate: 2 hours. FDA label; 1.8-2 h Population/route context and estimates may differ. This is not a schedule or a verified human dosing rule.

Source references

Snapshot provenance

Source ID: catalog:medication:ibuprofen. Commit: adc7684614f9439b41d91a3312b62e7982c7e20e. Review state: historical-not-reverified. Authored links are retained separately from the canonical evidence links in the public data. App templates/defaults and rejected drafts are archived, not deployed.

Related entries and components

None listed.